PPBI Form 144 Notice — 5,000 Common Shares via Fidelity ($112.7K)
Rhea-AI Filing Summary
Pacific Premier Bancorp, Inc. (PPBI) filed a Form 144 notifying the proposed sale of 5,000 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $112,700.00. The filing lists 96,991,440 shares outstanding and an approximate sale date of 08/12/2025.
The filer reports the shares were acquired on 08/12/2025 pursuant to options originally granted on 03/09/2016 and that payment for the shares will be in cash. The form states there were no sales in the past three months and includes the customary representation that the signer is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 filing for 5,000 shares; transaction appears administrative and immaterial to overall capitalization.
The Form 144 discloses a proposed sale of 5,000 common shares valued at $112,700 and scheduled for 08/12/2025 through Fidelity Brokerage Services LLC. The filing provides acquisition detail showing the position arose from options granted on 03/09/2016 and was recorded as acquired on 08/12/2025 with cash payment. It also reports no related sales in the prior three months, indicating this notice is an isolated transaction rather than part of a series of insider disposals. From a market-impact perspective, the absolute size is small relative to the reported 96,991,440 shares outstanding, suggesting limited direct effect on liquidity or valuation.
TL;DR: Filing reflects standard compliance with Rule 144 disclosure; signer affirms no undisclosed material adverse information.
The notice follows Rule 144 disclosure requirements by listing broker, quantity, aggregate market value, and acquisition history. The inclusion of the representation about material adverse information and the note regarding trading plans or Rule 10b5-1 indicates standard attestation language is present. The absence of reported sales during the past three months simplifies aggregation considerations under Rule 144. This appears to be a routine, transparent disclosure consistent with insider sale protocols rather than a corporate governance red flag.